Clinical Research, Pharma & Healthcare FinancingHepaRegeniX Raises €21.5M to Advance Liver Drug HRX-215GlobeNewswireApril 15, 2025April 16, 2025 by GlobeNewswireApril 15, 2025April 16, 20250123 HepaRegeniX GmbH (“HepaRegeniX”), a clinical-stage company advancing novel therapies to treat acute and chronic liver diseases, today announced the second closing and completion of a €21.5...